BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23136886)

  • 21. AMP-activated protein kinase: a target for old drugs against diabetes and cancer.
    Russo GL; Russo M; Ungaro P
    Biochem Pharmacol; 2013 Aug; 86(3):339-50. PubMed ID: 23747347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
    Sacco E; Spinelli M; Vanoni M
    Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation.
    Lin JT; Chen HM; Chiu CH; Liang YJ
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1253-65. PubMed ID: 24857754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance.
    Garcia D; Shaw RJ
    Mol Cell; 2017 Jun; 66(6):789-800. PubMed ID: 28622524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p38α mitogen-activated protein kinase inhibitors, a patent review (2005-2011).
    Fischer S; Koeberle SC; Laufer SA
    Expert Opin Ther Pat; 2011 Dec; 21(12):1843-66. PubMed ID: 22082194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMP-activated protein kinase and the metabolic syndrome.
    Fryer LG; Carling D
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):362-6. PubMed ID: 15787607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.
    Fogarty S; Hardie DG
    Biochim Biophys Acta; 2010 Mar; 1804(3):581-91. PubMed ID: 19778642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pim kinase inhibitors: a survey of the patent literature.
    Morwick T
    Expert Opin Ther Pat; 2010 Feb; 20(2):193-212. PubMed ID: 20100002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells.
    Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a potent and orally active activator of adenosine monophosphate-activated protein kinase (AMPK), ASP4132, as a clinical candidate for the treatment of human cancer.
    Kuramoto K; Yamada H; Shin T; Sawada Y; Azami H; Yamada T; Nagashima T; Ohnuki K
    Bioorg Med Chem; 2020 Mar; 28(5):115307. PubMed ID: 32007387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMP-activated protein kinase (AMPK) molecular crossroad for metabolic control and survival of neurons.
    Spasić MR; Callaerts P; Norga KK
    Neuroscientist; 2009 Aug; 15(4):309-16. PubMed ID: 19359670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 - 2013).
    Cheung CH; Sarvagalla S; Lee JY; Huang YC; Coumar MS
    Expert Opin Ther Pat; 2014 Sep; 24(9):1021-38. PubMed ID: 24965505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10).
    Cheung CH; Coumar MS; Chang JY; Hsieh HP
    Expert Opin Ther Pat; 2011 Jun; 21(6):857-84. PubMed ID: 21591849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase.
    Oh S; Kim SJ; Hwang JH; Lee HY; Ryu MJ; Park J; Kim SJ; Jo YS; Kim YK; Lee CH; Kweon KR; Shong M; Park SB
    J Med Chem; 2010 Oct; 53(20):7405-13. PubMed ID: 20873794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease.
    Hardie DG
    FEBS Lett; 2008 Jan; 582(1):81-9. PubMed ID: 18022388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a future for Aurora kinase inhibitors for anticancer therapy?
    Carpinelli P; Moll J
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AMPK signalling in health and disease.
    Carling D
    Curr Opin Cell Biol; 2017 Apr; 45():31-37. PubMed ID: 28232179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low salt concentrations activate AMP-activated protein kinase in mouse macula densa cells.
    Cook N; Fraser SA; Katerelos M; Katsis F; Gleich K; Mount PF; Steinberg GR; Levidiotis V; Kemp BE; Power DA
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F801-9. PubMed ID: 19176702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The regulation of AMP-activated protein kinase by upstream kinases.
    Carling D; Sanders MJ; Woods A
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S55-9. PubMed ID: 18719600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.